E ReTender for the supply of Anticancer Drugs
Tender Description
E ReTender for the supply of Anticancer Drugs to MCC-PGIOSR
Tender Specifications & Timeline
15 FieldsAward of Contract (AOC) Details
Awardee / Contractor
AbbVie Healthcare India Private Limited
Award Date: 26-Dec-2025
Completion Period: 14 Days
Contract Financials & Scope
INR 6,378,140
Contract awarded to qualified L1 firms
Contract Award Info Updated 08-Jan-2026 03:05 PM by SANDHYA DEVI KP
Total Bidders
4
Total Awarded Value
₹63.94 L
Estimated Value (PAC)
₹4.13 Cr
Margin vs Estimate
—
Winning Contractors (4 - Official Awardees)
Accepted-AOCCompletion Period
14 days
AOC Award Date
26-Dec-2025
| Rank | Bidder / Contractor | Quoted Bid | Gap vs L1 | vs Estimate | Status |
|---|---|---|---|---|---|
| L1 | ₹88,065 | 0.0% (L1) | — | Accepted-AOC | |
| L1 | ₹5.86 L | 0.0% (L1) | — | Accepted-AOC | |
| L1 | NATCO PHARMA LIMITED#2401900 | ₹16.76 L | 0.0% (L1) | — | Accepted-AOC |
| L1 | ₹40.44 L | 0.0% (L1) | — | Accepted-AOC |
This goods & services tender covers e ReTender for the supply of Anticancer Drugs, issued by Malabar Cancer Centre under reference MCC/251/2024-P3-GAD. The estimated contract value is ₹4.13 Cr, and the tender is currently Expired. Following contract finalisation, the work has been awarded to AbbVie Healthcare India Private Limited for a total value of ₹63.78 L.
This procurement is part of ongoing efforts by central government agencies and public sector undertakings to maintain and upgrade public infrastructure and services in MCC, Thalassery. Vendors interested in similar opportunities can browse other tenders from the same issuing organisation below.
As per financial evaluation report and negotiation decision
As per financial evaluation report and negotiation decision
As per financial evaluation report and negotiation decision
As per financial evaluation report and negotiation decision
| Bidder | Submitted On | Status | Fin. Value | Rank | Remarks / Logs |
|---|---|---|---|---|---|
AbbVie Healthcare India Private Limited #2392624 | 28-Oct-2025 03:01 PM | Accepted-AOC Updated: 08-Jan-2026 03:05 PM | 4044105.00 | L1 | As per financial evaluation report and negotiation decision |
Amneal Healthcare Private Limited #2412140 | 30-Oct-2025 09:30 AM | Accepted-AOC Updated: 08-Jan-2026 03:05 PM | 88065.00 | L1 | As per financial evaluation report and negotiation decision |
Celon Laboratories Private Limited #2392951 | 30-Oct-2025 03:30 PM | Accepted-AOC Updated: 08-Jan-2026 03:05 PM | 586490.00 | L1 | As per financial evaluation report and negotiation decision |
NATCO PHARMA LIMITED #2401900 | 27-Oct-2025 04:49 PM | Accepted-AOC Updated: 08-Jan-2026 03:05 PM | 1675625.00 | L1 | As per financial evaluation report and negotiation decision |
Bid Evaluation Details & Logs
technical bid opening
Date: 12-Nov-2025 10:37 AM
Officer: SANDHYA DEVI KP
Above bids are admitted for technical evaluation
technical evaluation
Date: 22-Dec-2025 09:58 AM
Officer: SANDHYA DEVI KP
finance bid opening
Date: 22-Dec-2025 10:30 AM
Officer: SANDHYA DEVI KP
Above bids are admitted for financial evaluation
finance evaluation
Date: 26-Dec-2025 09:54 AM
Officer: SANDHYA DEVI KP
About This Procurement Notice
This Kerala state government tender was issued by Malabar Cancer Centre. The estimated contract value is ₹4.13 Cr. Bids must be submitted by 30-Oct-2025 05:00 PM.
BiharInfraTales aggregates procurement notices from Bihar eProcurement, GeM portal, and central government tender portals. Data is refreshed every 30 minutes. Always verify details on the official portal before submitting a bid.
Frequently Asked Questions
- QWhat is the status of the tender "E ReTender for the supply of Anticancer Drugs"?
- The current status of this tender is "Expired". The submission deadline is 30-Oct-2025 05:00 PM. This information is sourced from official government procurement portals.
- QWho issued this Kerala government tender?
- This tender was issued by Malabar Cancer Centre. The reference number is MCC/251/2024-P3-GAD. It is a Kerala state government procurement notice.
- QWhat is the estimated value of this tender?
- The estimated tender value is ₹4.13 Cr. This is the approximate contract value as disclosed in the official tender document.
- QWho won the contract for this tender?
- The contract for "E ReTender for the supply of Anticancer Drugs" has been awarded to AbbVie Healthcare India Private Limited with an awarded contract value of ₹63.78 L.
- QWhat is the final awarded contract value?
- The final awarded contract value is ₹63.78 L (84.56% below the estimated PAC of ₹4.13 Cr).